NASDAQ:CRIS - Curis, Inc.
$1.08
 $0.04
+3.85%
1:40PM EDT
2019-02-15
Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of Class I and II HDAC, as well as Class I PI3K enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target programmed death ligand-1 (PDL1) and V-domain Ig suppressor of T-cell activation (VISTA) immune checkpoint proteins, both of which independently function as negative regulators of immune activation. CA-4948 is an oral small molecule drug candidate that is designed to inhibit the Interleukin-1 receptor-associated kinase 4 (IRAK4) kinase, which is a transducer of toll-like receptor or certain interleukin receptor signaling pathways. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CRIS     avg for
industry  
  avg for
sector  
42 stocks weight:  29. 52   0. 00   0. 00  
42 stocks rank:  3. 34 K 1. 86 K 1. 09 K
# analyst opinions:  2. 00   14. 92   14. 43  
mean recommendation:  1. 00   1. 91   1. 93  

quick ratio:  2. 55   5. 37   1. 81  
current ratio:  2. 63   5. 69   2. 19  

target price low:  0. 90   88. 97   117. 82  
target price avg:  1. 91   115. 19   141. 96  
target price high:  3. 00   143. 40   163. 16  
1-yr high:  4. 90   124. 30   142. 77  
last close:  1. 04   101. 85   127. 84  
50-day avg:  0. 95   98. 27   122. 46  
200-day avg:  1. 63   99. 72   122. 70  
1-yr low:  0. 62   78. 19   100. 16  
volume:  130. 94 K 2. 38 M 4. 64 M
50-day avg volume:  381. 22 K 3. 31 M 4. 94 M
200-day avg volume:  366. 84 K 3. 23 M 4. 28 M

1-day return:  -4. 59 % 0. 22 % 0. 48 %
this week return:  -1. 89 % 1. 77 % 2. 01 %
12-wk return:  -16. 80 % 6. 56 % 3. 33 %
52-wk return:  -60. 00 % -2. 23 % 14. 35 %

enterprise value (EV):  42. 08 M 55. 17 B 104. 51 B
market cap:  34. 44 M 49. 01 B 96. 46 B
EBITDA:  -31. 11 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 35   -91. 79   2. 29  
enterprise/revenue (EV/R):  3. 85   29. 84   23. 39  
total revenue:  10. 94 M 11. 28 B 40. 22 B
total debt:  37. 15 M 13. 73 B 16. 57 B
debt/equity:  4. 75 K 258. 01   110. 73  
net income (common):  -34. 66 M 2. 37 B 3. 58 B

shares outstanding:  33. 11 M 607. 99 M 1. 22 B
shares:  24. 40 M 605. 53 M 1. 15 B
shares short:  1. 39 M 11. 62 M 12. 55 M
shares short prior month:  1. 20 M 11. 95 M 13. 44 M
short ratio:  4. 03   4. 82   3. 10  
short % of float:  6. 24 % 6. 19 % 2. 82 %
total cash/share:  0. 93   12. 02   11. 46  
total cash:  30. 83 M 7. 41 B 7. 37 B
free cash flow:  -20. 27 M 95. 99 M 2. 04 B
operating cash flow:  -32. 63 M 164. 74 M 3. 04 B

book value:  0. 02   14. 43   28. 26  
price/book:  43. 33   -1. 57   -2. 97  
gross profits:  -35. 69 M 8. 28 B 18. 09 B
operating margins:  -286. 36 % -458. 01 % -642. 83 %
EBITDA margins:  -284. 55 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  -148. 75 % 49. 33 % 54. 53 %

1-yr max volatility:  31. 58 % --- ---
1-yr mean volatility:  -0. 16 % 0. 01 % 0. 06 %

1-yr EPS:  -1. 05   3. 03   4. 09  
forward EPS:  -0. 82   4. 33   6. 99  
P/E:  -0. 99   6. 11   26. 91  
forward P/E:  -1. 33   8. 38   10. 48  
PE/G:  -0. 06   0. 37   5. 61  
growth:  16. 50 % 683. 72 % 104. 79 %
earnings high:  -0. 21   1. 27   1. 66  
earnings avg:  -0. 22   1. 01   1. 53  
earnings low:  -0. 22   0. 76   1. 40  
revenue high:  2. 60 M 2. 86 B 11. 19 B
revenue avg:  2. 45 M 2. 78 B 10. 84 B
revenue low:  2. 29 M 2. 67 B 10. 64 B
return on assets:  -30. 91 % -3. 27 % 3. 81 %
return on equity:  -221. 99 % 107. 48 % 27. 82 %
revenue growth:  16. 50 % 648. 36 % 97. 70 %
revenue/share:  0. 33   14. 68   59. 83  

beta (1yr vs S&P500):  1. 73   1. 21   0. 93  
sharpe (1yr):  -0. 36   0. 06   0. 98  

held % insiders:  18. 01 % 6. 46 % 3. 21 %
held % institutions:  25. 11 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : CRIS
.        + 0 =             0 :: INITIAL WEIGHT
.  + 360.529 =       360.529 :: inverse volume-to-price addition
.   + 316.82 =       677.349 :: spline projection addition
.  - 213.465 =       463.883 :: poor performance penalty
.    x 0.625 =       289.702 :: one-year gains+dividend factor
.    x 2.755 =       798.151 :: 13 weeks' performance factor
.    x 1.492 =      1191.231 :: industry recommendation factor
.    x 2.713 =      3232.323 :: symbol recommendation factor
.    x 1.129 =      3649.202 :: EV/R factor
.    x 0.997 =      3637.922 :: return on assets factor
.    x 0.978 =      3557.166 :: return on equity factor
.    x 2.209 =      7859.088 :: revenue growth factor
.    x 2.462 =     19349.865 :: current ratio factor
.    x 1.283 =     24831.468 :: quick ratio factor
.    x 1.117 =     27741.751 :: short ratio factor
.    x 2.603 =     72208.636 :: price-to-book factor
.    x 2.252 =    162625.788 :: debt-to-equity factor
.    x 1.117 =    181715.477 :: 5-day avg > 50-day avg
.    x 2.171 =    394523.799 :: P/E weight
.     x 2.02 =    796855.785 :: PE/G factor
.    x 1.579 =   1257943.463 :: beta factor
.    x 0.359 =    451914.859 :: sharpe factor
.    x 0.963 =    435334.117 :: target low factor
.    x 1.305 =    568045.841 :: target mean factor
.    x 1.137 =    646027.909 :: target high factor
.    x 1.066 =    688415.614 :: industry 12-weeks return
.    x 0.882 =    607089.537 :: "drift" penalty 1 days ago
.    x 0.999 =     606709.65 :: overall "drift" factor
.    x 0.684 =    415117.102 :: largest single-day jump factor
.    x 0.062 =     25719.771 :: low price factor
.      x 1.0 =     25721.497 :: factor hist industry gain for week 06
.   cubeRoot =        29.519 :: reduced for readability
.                     29.519 :: FINAL WEIGHT for NASDAQ:CRIS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org